King Pharmaceuticals®, Inc.

238 articles about King Pharmaceuticals®, Inc.

• King Pharmaceuticals®, Inc.To Acquire Alpharma Inc. for Approximately $1.6 Billion

  11/24/2008

• FDA Panel Mixed on King Pharmaceuticals®, Inc., Pain Therapeutics Drug; FDA Scheduled to Act By December 10 Under Six-Month Priority Review

  11/14/2008

• US FDA Staff Question FDA, King Pharmaceuticals®, Inc. Data

  11/10/2008

• King Pharmaceuticals®, Inc. Reports Third-Quarter 2008 Financial Results

  11/6/2008

• King Pharmaceuticals®, Inc. Announces Date for Release of Third-Quarter 2008 Financial Results

  10/22/2008

• King Pharmaceuticals®, Inc. Extends Tender Offer to Acquire Alpharma Inc.

  10/13/2008

• Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. Announce Positive Top Line Results of Key Clinical Study Assessing Abuse Liability

  10/13/2008

• Alpharma Inc. and King Pharmaceuticals®, Inc. Enter into Confidentiality Agreement

  10/6/2008

• Alpharma Inc. Rejects King Pharmaceuticals®, Inc.'s Offer as Inadequate

  9/26/2008

• King Pharmaceuticals®, Inc. Ups Alpharma Inc. Offer to $1.6 Billion, Goes Hostile

  9/12/2008

• King Pharmaceuticals®, Inc. Ups Alpharma Inc. Offer, Will Go to Shareholders

  9/11/2008

• Alpharma Inc. Urges Shareholders to Take No Action with Respect to King Pharmaceuticals®, Inc.' Announced Intent to Commence a Tender Offer

  9/11/2008

• Pain Therapeutics Receives $20,000,000.00 from King Pharmaceuticals®, Inc.

  9/2/2008

• Alpharma Inc. Adopts Rights Plan to Thwart King Pharmaceuticals®, Inc. Bid

  9/2/2008

• King Pharmaceuticals®, Inc. to Present at Thomas Weisel Partners Healthcare Conference

  8/29/2008

• Pain Therapeutics and King Pharmaceuticals®, Inc. Develop a New Abuse-Resistant Prescription Pain Medication

  8/27/2008

• King Pharmaceuticals®, Inc. Provides Updated Replay Information for Conference Call Regarding Proposed Acquisition of Alpharma Inc.

  8/25/2008

• King Pharmaceuticals®, Inc. Proposes Acquisition of Alpharma Inc.; King Discloses Rejected $1.43 Billion Bid

  8/22/2008

• Pain Therapeutics and King Pharmaceuticals®, Inc. Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland

  8/19/2008

• FDA Accepts Pain Therapeutics, King Pharmaceuticals®, Inc. REMOXY New Drug Application and Grants Priority Review

  8/12/2008